In News

Follow this topic

Bookmark

Record learning outcomes

Actavis has continued to expand its generics portfolio with the launch of 30 new products this year, in addition to the 54 products the company acquired from its takeover of Auden McKenzie.

Jonathan Wilson, Actavis UK managing director, commented: €In 2015 we have added numerous key products to our generics offering and we continue to invest in new technologies so that we can expand our portfolio and adapt to our valued customers' needs.€